Irinotecan versus infusional 5-fluorouracil: a phase III study in metastatic colorectal cancer following failure on first-line 5-fluorouracil. V302 Study Group. [electronic resource]
Producer: 19990422Description: 13-20 p. digitalISSN:- 0093-7754
- Antimetabolites, Antineoplastic -- therapeutic use
- Antineoplastic Agents, Phytogenic -- therapeutic use
- Camptothecin -- analogs & derivatives
- Colorectal Neoplasms -- drug therapy
- Female
- Fluorouracil -- therapeutic use
- Humans
- Irinotecan
- Male
- Middle Aged
- Multivariate Analysis
- Neoplasm Metastasis
- Quality of Life
- Survival Analysis
- Topoisomerase I Inhibitors
- Treatment Failure
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase III; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.